公司概覽
業務類別 --
業務概覽 Ascletis Pharma Inc is an investment holding company. Along with its subsidiaries, it is engaged in the research and development, production, marketing, and sale of pharmaceutical products. The drug candidates of the company in the pipeline in their different stages of development such as ASC30, ASC47, ASC39, ASC36i, ASC35, ASC50, and among others.
公司地址 No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG, 311200
電話號碼 +86 18106509129
傳真號碼 +86 57185389730
公司網頁 https://www.ascletis.com
員工數量 202
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jinzi Jason Wu Chairman of the Board and Chief Executive Officer -- 29/04/2026
Ms. Judy Hejingdao Wu Director and Senior Vice President, Operations -- 29/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Jiong Gu Independent Director 29/04/2026
Dr. Jinzi Jason Wu Chairman of the Board and Chief Executive Officer 29/04/2026
Ms. Judy Hejingdao Wu Director and Senior Vice President, Operations 29/04/2026
Dr. Yizhen Wei Independent Director 29/04/2026
Ms. Lin Hua Independent Director 29/04/2026
 
所屬ETF (更新日期: 18/07/2026 03:58)
代號 名稱 佔比% 持有日期
IEMGiShares Core MSCI Emerging Markets ETF0.24%30/06/2026
SPEMState Street® SPDR® Portfolio EM ETF0.07%30/06/2026
AVEEAvantis Emerging Markets Sm Cp Eq ETF<0.000001%16/08/2025
AVEMAvantis Emerging Markets Equity ETF<0.000001%16/08/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.